Simcere Pharma ^Investors

Simcere Pharma is a leading manufacturer and supplier of branded generic pharmaceuticals in China. Founded in 1995, the company has quickly grown to become a major player in the rapidly expanding Chinese pharmaceutical market. With five GMP-certified manufacturing facilities, two sales and marketing subsidiaries, and a dedicated research and development center, Simcere is committed to providing high-quality drugs to meet the healthcare needs of the Chinese population. Their achievements include being the first Chinese chemical and biological drug company to list on the New York Stock Exchange, raising $261 million in IPO proceeds.